Brief: Somalogic Announces License Agreement With Oncohost For The Development Of Precision Cancer Diagnostics
13/06/2022 13:24
June 13 (Reuters) - Somalogic Inc SLGC.O :
* SOMALOGIC ANNOUNCES LICENSE AGREEMENT WITH ONCOHOST FOR
THE
DEVELOPMENT OF PRECISION CANCER DIAGNOSTICS
* SOMALOGIC INC- ONCOHOST WILL LICENSE SOMALOGIC'S SOMASCAN
PLATFORM TO DEVELOP PROTEOMICS TESTS FOR ITS PROPHET DIAGNOSTIC
SYSTEM
Source text for Eikon: ID:nGNX67KM1W
Further company coverage: SLGC.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders